Horizon Therapeutics Public Ltd Co Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Horizon Therapeutics Public Ltd Co quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2023.
  • Horizon Therapeutics Public Ltd Co Operating Income (Loss) for the quarter ending June 30, 2023 was $143M, a 61.3% increase year-over-year.
  • Horizon Therapeutics Public Ltd Co Operating Income (Loss) for the twelve months ending June 30, 2023 was $513M, a 39.4% decline year-over-year.
  • Horizon Therapeutics Public Ltd Co annual Operating Income (Loss) for 2022 was $617M, a 13.7% increase from 2021.
  • Horizon Therapeutics Public Ltd Co annual Operating Income (Loss) for 2021 was $543M, a 10.8% increase from 2020.
  • Horizon Therapeutics Public Ltd Co annual Operating Income (Loss) for 2020 was $490M, a 287% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $513M $143M +$54.3M +61.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $459M $36M -$158M -81.5% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $617M $174M -$59.2M -25.4% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-01
Q3 2022 $677M $161M -$171M -51.6% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $848M $88.6M -$50M -36.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $897M $194M +$354M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $543M $233M -$6.98M -2.91% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-01
Q3 2021 $550M $332M +$103M +45% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $447M $139M +$101M +266% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $346M -$160M -$144M -870% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $490M $240M +$185M +339% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-24
Q3 2020 $305M $229M +$180M +370% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $125M $37.9M +$12.8M +50.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $112M -$16.5M -$14.7M -819% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $127M $54.7M -$27.8M -33.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-24
Q3 2019 $154M $48.6M -$13.6M -21.8% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-24
Q2 2019 $168M $25.1M +$14.6M +138% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-24
Q1 2019 $153M -$1.8M +$116M +98.5% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-24
Q4 2018 $37.9M $82.5M +$150M Oct 1, 2018 Dec 31, 2018 10-K 2020-02-26
Q3 2018 -$112M $62.2M +$87.7M Jul 1, 2018 Sep 30, 2018 10-K 2020-02-26
Q2 2018 -$200M $10.6M +$196M Apr 1, 2018 Jun 30, 2018 10-K 2020-02-26
Q1 2018 -$396M -$117M -$12.1M -11.5% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-26
Q4 2017 -$383M -$67.3M +$62.8M +48.2% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-27
Q3 2017 -$446M -$25.5M -$4.18M -19.6% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-27
Q2 2017 -$442M -$185M -$217M -689% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-27
Q1 2017 -$225M -$105M -$78M -287% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-27
Q4 2016 -$147M -$130M -$168M -442% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-28
Q3 2016 $21M -$21.3M -$67.1M -147% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-28
Q2 2016 $88M $31.5M +$64.6M Apr 1, 2016 Jun 30, 2016 10-K 2018-02-28
Q1 2016 $23.4M -$27.2M -$32M -671% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-28
Q4 2015 $55.4M $38M +$29.1M +324% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-27
Q3 2015 $26.3M $45.7M +$57.7M Jul 1, 2015 Sep 30, 2015 10-K 2017-02-27
Q2 2015 -$31.4M -$33.2M -$26.1M -367% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-27
Q1 2015 -$5.31M $4.76M +$3.18M +200% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-27
Q4 2014 -$8.49M $8.98M +$14.7M Oct 1, 2014 Dec 31, 2014 10-K 2016-02-29
Q3 2014 -$23.2M -$12M -$9.22M -336% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-29
Q2 2014 -$14M -$7.1M +$8.7M +55.1% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-29
Q1 2014 -$22.7M $1.59M +$20.1M Jan 1, 2014 Mar 31, 2014 10-K 2016-02-29
Q4 2013 -$42.9M -$5.76M +$16.3M +73.8% Oct 1, 2013 Dec 31, 2013 10-K/A 2015-03-02
Q3 2013 -$59.1M -$2.74M +$16M +85.3% Jul 1, 2013 Sep 30, 2013 10-K/A 2015-03-02
Q2 2013 -$75.1M -$15.8M +$2.54M +13.9% Apr 1, 2013 Jun 30, 2013 10-K/A 2015-03-02
Q1 2013 -$77.6M -$18.5M +$1.24M +6.29% Jan 1, 2013 Mar 31, 2013 10-K/A 2015-03-02
Q4 2012 -$78.9M -$22M +$67.2M +75.3% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-13
Q3 2012 -$146M -$18.7M -$3.06M -19.5% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-13
Q2 2012 -$143M -$18.3M -$9.6M -110% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-13
Q1 2012 -$133M -$19.8M -$12.8M -183% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-13
Q4 2011 -$121M -$89.2M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-18
Q3 2011 -$15.7M -$4.05M -34.9% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-18
Q2 2011 -$8.75M +$3.21M +26.9% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-18
Q1 2011 -$6.99M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-18
Q3 2010 -$11.6M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$12M Apr 1, 2010 Jun 30, 2010 10-Q 2011-09-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.